Lucid Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	27.88	34.71	22.36	18.9	22.47	53.66
Cash & Short-Term Investments	27.88	34.71	22.36	18.9	22.47	53.66
Cash Growth	10.45%	55.22%	18.32%	-15.92%	-58.12%	48238.74%
Accounts Receivable	0.69	0.64	0.05	0.05	0.02	0.2
Inventory	0.47	0.35	0.34	0.28	0.11	-
Other Current Assets	2.33	1.77	2.4	2.85	1.75	3.45
Total Current Assets	31.36	37.47	25.15	22.07	24.36	57.3
Net Property, Plant & Equipment	2.5	2.62	3.7	2.64	3.6	0.97
Other Intangible Assets	0.21	0.32	0.74	1.42	3.45	-
Other Long-Term Assets	0.01	0.05	1.13	1.13	1.11	0.73
Total Assets	34.08	40.45	30.72	27.27	32.51	59
Accounts Payable	1.08	0.97	1.24	1.15	1.06	1.49
Accrued Expenses	2.2	2.72	2.83	3.84	1.45	1.11
Short-Term Debt	25.2	24	18.6	13.95	-	-
Current Portion of Leases	0.91	0.89	0.85	1.11	0.96	-
Other Current Liabilities	-	-	-	9.34	4.96	1.66
Total Current Liabilities	29.39	28.58	23.52	29.38	8.43	4.26
Long-Term Leases	0.7	0.93	1.8	0.2	1.04	-
Total Long-Term Liabilities	0.7	0.93	1.8	0.2	1.04	-
Total Liabilities	30.08	29.51	25.32	29.58	9.46	4.26
Preferred Stock	10.13	54.27	54.42	18.63	-	-
Common Stock	0.17	0.13	0.06	0.04	0.04	0.04
Additional Paid-in Capital	291.66	230.87	154.68	129.76	121.08	96.61
Retained Earnings	-297.96	-274.34	-203.77	-150.74	-98.08	-41.9
Shareholders' Equity	4	10.94	5.39	-2.31	23.05	54.74
Total Liabilities & Equity	34.08	40.45	30.72	27.27	32.51	59
Total Debt	26.8	25.82	21.25	15.26	2	0
Net Cash (Debt)	1.07	8.89	1.1	3.64	20.48	53.66
Net Cash Growth	-87.92%	704.80%	-69.68%	-82.22%	-61.84%	48238.74%
Net Cash Per Share	0.01	0.09	0.02	0.07	0.33	2.00
Book Value	4	10.94	5.39	-2.31	23.05	54.74
Book Value Per Share	0.03	0.11	0.11	-0.05	0.37	2.04
Tangible Book Value	3.79	10.62	4.66	-3.74	19.6	54.74
Tangible Book Value Per Share	0.03	0.10	0.09	-0.07	0.31	2.04

SEC Filings: 10-K · 10-Q